Filing Details

Accession Number:
0001104659-17-017606
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-17 16:16:24
Reporting Period:
2017-03-15
Filing Date:
2017-03-17
Accepted Time:
2017-03-17 16:16:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1248144 Adrian Adams C/o Aralez Pharmaceuticals Inc.,
7100 West Credit Avenue, Suite 101
Mississauga A6 L5N 0E4
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Acquisiton 2017-03-15 500,000 $2.46 3,569,230 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $2.305 to $2.600. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.